• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Mela adds five to board of directors to replace four outgoing members | Personnel Moves

Mela adds five to board of directors to replace four outgoing members | Personnel Moves

December 12, 2011 By MassDevice staff

Mela Sciences logo

Mela Sciences (NSDQ:MELA) added five new members to its board of directors this month, looking to tap their expertise in advance of a planned launch in the U.S. and Germany in the first quarter of 2012.

The Irvington, N.Y.-based company named the new directors on the heels of two regulatory wins granting its flagship skin cancer detection device MelaFind market access in the U.S. and Europe.

Mela won FDA clearance early last month after more than two years in regulatory limbo, and landed CE Mark approval in the European Union in September.

"The FDA approval of MelaFind marks the most important achievement in the company’s history and represents a significant advance for the millions of Americans who are at risk of developing this terrible disease," president & CEO Dr. Joseph Gulfo said in November.

Click here to listen to the MassDevice podcast interview with Mela Sciences CEO Dr. Joseph Gulfo

Mela’s new board members come in to replace outgoing directors Sidney Braginsky and George Chryssis, both members since 2001, as well as Breaux Castleman, member since 2003, and Gerald Wagner, director since 2005.

Dr. Gulfo added, "Having achieved FDA and CE Mark approvals in 2011, it is with bittersweet emotion that we effect these changes to our Board, saying goodbye to directors who have served multiple tours in our fight to win the product approvals," president & CEO Joseph Gulfo said in prepared remarks. "We sincerely thank Messrs. Braginsky, Castleman, Chryssis and Dr. Wagner for their excellent contributions, without which we could not have succeeded, and we wish them well."

Mela’s new directors are:

  • Robert Coradini, Johnson & Johnson (NYSE:JNJ) veteran.

  • Mark Fabiani, former special counsel to President Clinton.
  • John Goddard, former CFO for AstraZeneca U.S.
  • James Noble, CEO of Immunocore
  • David Stone, founder and managing director of Liberty Tree Advisors, LLC

    "With FDA and CE Mark approval of our breakthrough product, MelaFind, we are now a commercial-stage company, and we look to the expertise of our new directors in the fields of international sales and marketing, investor and public relations, accounting, business development, and strategic planning as we prepare for our first quarter 2012 product launches in the US and Germany," said Gulfo added.

    MassDevice.com Personnel Moves

    Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.

    Intrinsic Therapeutics names new president & CEO
    Woburn, Mass.-based spinal therapies maker Intrinsic Therapeutics named Cary Hagan president & CEO. Read more

    DJO Global announces COO departure
    DJO Global Inc., a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, announced the resignation of Luke Faulstick, executive VP and COO, who will depart in early February, 2012.  Read more

    Competitive Technologies gets new board chairman
    Competitive Technologies Inc. (PINK:CTTC) announced that Rustin R. Howard, who has served as a director of CTTC since October of 2007, has been elected chairman of its board of directors, effective immediately.   Read more

    SuccessEHS names new chief medical officer
    SuccessEHS named Dr. Claude Ouimet, former deputy health officer at Jefferson County Dept. of Health, its new chief medical officer.  Read more

Filed Under: News Well, Oncology Tagged With: Competitive Technologies Inc., DJO Global, Intrinsic Therapies, MELA Sciences Inc., Personnel Moves, SuccessEHS

More recent news

  • Imperative Care, Proximie partner to develop surgical robot to treat stroke
  • Carlsmed launches IPO roadshow
  • Varian introduces IntelliBlate for image-guided cancer therapy in Europe
  • Henry Schein CEO Stanley M. Bergman to retire
  • Medtronic wins CE mark for LigaSure sealing tech for Hugo surgical robot

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy